CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Biofrontera Bioscience GmbH

For profitWebsite ↗

Also known as: BIOFRONTERA | Biofrontera Bioscience GmbH | Biofrontera, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 2006

First marketed drug

Nov 27, 2000

Last known activity

Jun 27, 2025

Timeline

1990s

  1. Jul 1, 1997

    Biofrontera Bioscience GmbH— Founded

2000s

  1. Nov 27, 2000

    erythromycin— NDA Secondary Org

2010s

  1. Mar 25, 2019

    Cutanea Life Sciences, Inc.— Acquired

Drugs by trial phase (8 distinct, 35 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (1 own, 2 via acquisition)

Phase 2 (0 own, 3 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (15)

Details

Founded
Leverkusen, DE Jul 1, 1997
Last known activity
Jun 27, 2025